ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.52
-1.13%
US Tech 100
20,263.20
-1.69%
S&P 500
5,827.04
-1.54%
US Dollar vs CAD
1.4426
-0.66%
Bitcoin
94,552.93
-0.16%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. ProQR Therapeutics NV (PRQR) Share Price

ProQR Therapeutics NV

ProQR Therapeutics NV (PRQR)

NASDAQ
2.42
-0.20
(-7.63%)
Closed January 11 3:00PM
Delayed by 15 minutes
2.42
0.00
(0.00%)
After Hours: 5:55PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
2.42
Bid
2.32
Ask
2.50
Volume
346,939
2.40 Day's Range 2.68
1.61 52 Week Range 4.62
Market Cap
196.878M
Previous Close
2.62
Open
2.59
Last Trade
15
@
2.42
Last Trade Time
Financial Volume
US$ 851,170
VWAP
2.4534
Average Volume (3m)
681,069
Shares Outstanding
81,354,592
Dividend Yield
-
PE Ratio
-7.00
Earnings Per Share (EPS)
-0.35
Revenue
6.59M
Net Profit
-28.12M

About ProQR Therapeutics NV

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.proqr.com
Headquarters
Leiden, South Holland, Nld
Founded
-
ProQR Therapeutics NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PRQR. The last closing price for ProQR Therapeutics NV was US$2.62. Over the last year, ProQR Therapeutics NV shares have traded in a share price range of US$ 1.61 to US$ 4.62.

ProQR Therapeutics NV currently has 81,354,592 shares outstanding. The market capitalization of ProQR Therapeutics NV is US$213.15 million. ProQR Therapeutics NV has a price to earnings ratio (PE ratio) of -7.00.

Ask ADVFN Intelligence (AI)

PRQR Latest News

More News

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]

December 12 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

December 11 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

December 11 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

December 10 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

December 05 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

November 07 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

October 25 2024
Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]

October 24 2024
Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]

October 23 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

October 10 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.33-122.752.822.422608772.6498971CS
4-0.85-25.9938837923.273.272.2655459502.63431272CS
12-2.06-45.98214285714.484.572.2656810693.42896781CS
260.7544.91017964071.674.621.658383663.66703646CS
520.4623.46938775511.964.621.615316203.37474531CS
156-4.55-65.27977044486.977.450.538288822.28556077CS
260-6.59-73.1409544959.019.460.538028944.25854367CS

PRQR - Frequently Asked Questions (FAQ)

What is the current ProQR Therapeutics NV share price?
The current share price of ProQR Therapeutics NV is US$ 2.42
How many ProQR Therapeutics NV shares are in issue?
ProQR Therapeutics NV has 81,354,592 shares in issue
What is the market cap of ProQR Therapeutics NV?
The market capitalisation of ProQR Therapeutics NV is USD 213.15M
What is the 1 year trading range for ProQR Therapeutics NV share price?
ProQR Therapeutics NV has traded in the range of US$ 1.61 to US$ 4.62 during the past year
What is the PE ratio of ProQR Therapeutics NV?
The price to earnings ratio of ProQR Therapeutics NV is -7
What is the cash to sales ratio of ProQR Therapeutics NV?
The cash to sales ratio of ProQR Therapeutics NV is 29.84
What is the reporting currency for ProQR Therapeutics NV?
ProQR Therapeutics NV reports financial results in EUR
What is the latest annual turnover for ProQR Therapeutics NV?
The latest annual turnover of ProQR Therapeutics NV is EUR 6.59M
What is the latest annual profit for ProQR Therapeutics NV?
The latest annual profit of ProQR Therapeutics NV is EUR -28.12M
What is the registered address of ProQR Therapeutics NV?
The registered address for ProQR Therapeutics NV is ZERNIKEDREEF 9, LEIDEN, SOUTH HOLLAND, 2333 CK
What is the ProQR Therapeutics NV website address?
The website address for ProQR Therapeutics NV is www.proqr.com
Which industry sector does ProQR Therapeutics NV operate in?
ProQR Therapeutics NV operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.7M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.69M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.56M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.16B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.45M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.81M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.85M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.44M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
207.53M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
178.82M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
175.57M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M

PRQR Discussion

View Posts
TechandBio TechandBio 4 weeks ago
Sold last week after management seems dis-organized and European companies are risky and these guys are so far early in their clinical development.

$PRQR
👍️0
PonkenPlonken PonkenPlonken 1 month ago
CEO says to expect updates of what LLY has been up to in RNA editing in 2025.
👍️0
PonkenPlonken PonkenPlonken 2 months ago
LLY participate in offering on top of 3.5bn deal... at 3.50 strike
i believe 5$ next

https://www.globenewswire.com/news-release/2024/10/23/2967435/33039/en/ProQR-Prices-75-Million-Underwritten-Public-Offering-and-Concurrent-Private-Placement.html
👍️0
TechandBio TechandBio 2 months ago
Doubling my position here today!

Love this technology and team

$PRQR
👍️0
TechandBio TechandBio 2 months ago
PRQR is WVE 2.0

Glad I loaded the day before the break out!

100k shares long Love the Lily connection and brain power from ALNY at PRQR very early pipeline buy out sooner than later.

Lily owns over 16% of PRQR

$PRQR
👍️0
glenn1919 glenn1919 2 months ago
PRQR.........................https://stockcharts.com/h-sc/ui?s=PRQR&p=W&b=5&g=0&id=p86431144783
👍️0
PonkenPlonken PonkenPlonken 3 months ago
Now over 4 and still no offering after the stock doubled this week on the WVE RNA success. Believe 6$ coming.

Still has this deal with LLY:
https://finance.yahoo.com/news/eli-lilly-inks-another-rna-105803336.html

doubling down in 2022:
https://finance.yahoo.com/news/proqr-therapeutics-shares-soar-eli-135337366.html
👍️0
glenn1919 glenn1919 3 months ago
PRQR............................https://stockcharts.com/h-sc/ui?s=PRQR&p=W&b=5&g=0&id=p86431144783
👍️0
TechandBio TechandBio 3 months ago
Looks interesting need to do more DD

may take a starter here soon.

$PRQR
👍️0
Monksdream Monksdream 4 months ago
PRQR under $3
👍️0
PonkenPlonken PonkenPlonken 5 months ago
the companies IR signals they are far from letting the LLY deal sour, 4bn in milestones, next payments are due soon.

LLY left none of their darligns behind so far,
👍️0
Monksdream Monksdream 6 months ago
PRQR under $2
👍️0
Monksdream Monksdream 6 months ago
PRQR under $2
👍️0
Monksdream Monksdream 8 months ago
PRQR under $2
👍️0
PonkenPlonken PonkenPlonken 9 months ago
added 2.01 hoping for love from LLY, 4bln in milestones.
👍️0
glenn1919 glenn1919 10 months ago
PRQR.....................................https://stockcharts.com/h-sc/ui?s=PRQR&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 10 months ago
PRQR............................https://stockcharts.com/h-sc/ui?s=PRQR&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 11 months ago
PRQR under $2
👍️0
Monksdream Monksdream 1 year ago
PRQR under $2
👍️0
AJ Freely AJ Freely 1 year ago
$PRQR - 👆Up 7.3% Pre-Market/ Current Price $1.65
Announce Agreement for Théa to Acquire ProQR’s Sepofarsen and Ultevursen Ophthalmic Assets
👍️0
KeepOn KeepOn 2 years ago
Nice rebound!
👍️0
Alan Brown Alan Brown 2 years ago
$0.4~
👍️0
Alan Brown Alan Brown 2 years ago
Ya....
👍️0
subslover subslover 2 years ago
Eli Lilly sends ProQR 35% higher after expanding RNA editing deal

https://seekingalpha.com/news/3919739-prqr-stock-surges-as-eli-lilly-expands-rna-editing-deal
👍️0
TommyBoyTrader9460 TommyBoyTrader9460 2 years ago
$PRQR Strong break up the chart..on watch next week

https://stockcharts.com/c-sc/sc?s=PRQR&p=D&b=5&g=0&i=0&r=1668863394516
👍️0
MADDSTACKER MADDSTACKER 3 years ago
Time for a bounce … I hope :)
👍️0
KeepOn KeepOn 3 years ago
$4 is the lowest consensus I can find here:
https://etfdailynews.com/news/proqr-therapeutics-nasdaqprqr-pt-lowered-to-8-00/

What say you?

Also, when do we know it stopped dropping?
👍️0
jaggerxj6 jaggerxj6 3 years ago
....looking for a 80 cent deadcat bounce?????
👍️0
swampboots swampboots 3 years ago
PRQR holding steady in market colapse odds are for up in 3 days.
👍️0
swampboots swampboots 3 years ago
PRQR 1.38 start.
👍️0
stockguard stockguard 3 years ago
ProQR Therapeutics SCHEDULE 13G 02/04/2022
Amended: It`s a boy!!!!!!!!! Really they only missed a 100,000 shares bought by Wellington Management Group LLP that is runs a lot of Vanguard and ETF funds.....
https://www.streetinsider.com/SEC+Filings/Form++SC+13GA+++ProQR+Therapeutics+N.V.++++++++++++++++Filed+by%3A+WELLINGTON+MANAGEMENT+GROUP+LLP/19559743.html
👍️0
JohnLocke101 JohnLocke101 3 years ago
nm
👍️0
JohnLocke101 JohnLocke101 3 years ago
Important area here for PRQR in the 8.40ish resistance. Hopefully we can get a volume surge.
👍️0
JohnLocke101 JohnLocke101 3 years ago
Some Nov/Dec call options with $10 strike traded today.. time for the pps to get up there. Looking stable going into 2022. Q 1/2 will be big.
👍️0
JohnLocke101 JohnLocke101 3 years ago
Im liking the setup. Come on PRQR, make the move. Bollinger says we’re close.
👍️0
MADDSTACKER MADDSTACKER 3 years ago
Lilly earnings tomorrow wonder if we get a mention
👍️0
JohnLocke101 JohnLocke101 3 years ago
Investment Case On ProQR Therapeutics Gets More Enticing
👍️0
murocman murocman 3 years ago
Looks like the high 7’s are even better! Man somebody took the air out of this balloon today.

Murocman
👍️0
JohnLocke101 JohnLocke101 3 years ago
Low $8’s is a great place to add, me thinks.
👍️0
MADDSTACKER MADDSTACKER 3 years ago
You to
👍️0
JohnLocke101 JohnLocke101 3 years ago
Yep. Editas data validated PRQR. Continued new highs coming.

Good Luck!
👍️0
MADDSTACKER MADDSTACKER 3 years ago
News out , nice volume
👍️0
MADDSTACKER MADDSTACKER 3 years ago
Sweet
👍️0
JohnLocke101 JohnLocke101 3 years ago
I see indications that PRQR is about to make a move up. We’ll see..
👍️0
MADDSTACKER MADDSTACKER 3 years ago
Mind if I ask what you saw ?
👍️0
JohnLocke101 JohnLocke101 3 years ago
I think options activity is getting interesting.
👍️0
MADDSTACKER MADDSTACKER 3 years ago
What do you think of these guys ? Seems like $50 at some point ?
👍️0
JohnLocke101 JohnLocke101 3 years ago
Oops. Sorry about that.

Oligonucleotides to treat eye disease
👍️0
MADDSTACKER MADDSTACKER 3 years ago
Is that for prqr ?
👍️0
JohnLocke101 JohnLocke101 3 years ago
New Patent
👍️0

Your Recent History

NASDAQ
PRQR
ProQR Therapeutics NV
BOV
BBFI11B
BB Fundo Invest Imobilia...
BOV
LWSA3
LOCAWEB ON
BIT
UB7RUQ
Unicredit Bank
BIT
P1Y839
NLBNPIT1Y839 20991231 36...
TSXV
PMO.H
Prime City One Capital
BOV
HGAG11
High Fundo de Investimen...
BIT
F18887
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads